Review: Vaginal signs and symptoms perform poorly in diagnosing vaginal candidiasis

Nardone, David A.; Anderson, Matt; Klink, Kathleen; Cohrssen, Andreas
March 2005
ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, pA13
Academic Journal
Presents several letters to the editor referencing articles and topics published in earlier issues of the journal "ACP Journal Club." Statement that vaginal signs and symptoms perform poorly in diagnosing vaginal candidiasis; Discussion on the emphasis of the value of the lack of odor in bacterial vaginosis and lack of yellow discharge in vaginal trichomoniasis; Symptoms for diagnosis of vaginal trichomoniasis.


Related Articles

  • Candiden Vaginal Tablet.  // Royal Society of Medicine: Medicines;2002, p133 

    This article provides information on Candiden Vaginal Tablet, a proprietary, non-prescription preparation of the antifungal drug clotrimazole. It can be used particularly to treat vaginal thrush. It is available as a vaginal tablet, and is not given to children, except on medical advice.

  • Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit. Lo Cascio, G.; Koncan, R.; Stringari, G.; Russo, A.; Azzini, A.; Ugolini, A.; Ligozzi, M.; Polati, E.; Cornaglia, G.; Concia, E.; Schweiger, V. // European Journal of Clinical Microbiology & Infectious Diseases;Feb2015, Vol. 34 Issue 2, p357 

    Invasive fungal infections (IFIs) are an increasing problem in intensive care units (ICUs), and conventional diagnostic methods are not always reliable or timely enough to deliver appropriate antimicrobial therapy. The dosage of fungal antigens in serum is a promising diagnostic technique, but...

  • Treatment of Vaginal Infections with Intravaginal Pentamycin in Clinical Practice. Balmer, Joseph A. // Internet Journal of Gynecology & Obstetrics;2009, Vol. 11 Issue 1, p20 

    Objectives: To evaluate the effectiveness of intravaginal pentamycin, a polyene antibiotic with a broad spectrum of antimicrobial activity, for the treatment of vaginal infections in clinical practice. Methods: This study was conducted on 159 women (aged 17-65 years) with vaginal infections...

  • Antifungals in Systemic Neonatal Candidiasis. Frattarelli, Daniel A.C.; Reed, Michael D.; Giacoia, George P.; Aranda, Jacob V. // Drugs;2004, Vol. 64 Issue 9, p949 

    Fungal infections are common in the newborn period, especially among premature neonates, and are responsible for considerable morbidity and mortality. Currently, three classes of antifungals are commonly used in the treatment of systemic fungal infections in neonates: the polyene macrolides...

  • Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? Oxman, David A.; Chow, Jennifer K.; Frendl, Gyorgy; Hadley, Susan; Hershkovitz, Shay; Ireland, Peter; McDermott, Laura A.; Tsai, Katy; Marty, Francisco M.; Kontoyiannis, Dimitrios P.; Golan, Yoav // Journal of Antimicrobial Chemotherapy (JAC);Jul2010, Vol. 65 Issue 7, p1460 

    Background: Candidaemia is often treated with fluconazole in the absence of susceptibility testing. We examined factors associated with candidaemia caused by Candida isolates with reduced susceptibility to fluconazole.

  • Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis. Friese, K.; Neumann, G.; Siebert, J. // Archives of Gynecology & Obstetrics;Aug2003, Vol. 268 Issue 3, p194 

    The aim of this prospective, multicenter, randomized, case-control study was to investigate the efficacy of a nonspecific mucosal antiseptic (octenidine dihydrochloride, phenoxyethanol) with proven antifungal effects, in patients with acute symptomatic vaginal candidosis, in comparison with a...

  • Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. Wang, J. L.; Chang, C. H.; Young-Xu, Y. // Journal of Invasive Fungal Infections;2010, Vol. 4 Issue 4, p152 

    In this meta-analysis, the authors evaluated the hepatotoxicity of antifungal agents in the treatment of invasive fungal infections, and examined whether hepatotoxicity was the cause of treatment discontinuation and study withdrawal. The risk of hepatotoxicity was higher in patients with...

  • Classification Of Fungal Infections And General Applications Of Anti Fungal Agents. Priyanka K.; Rani, V. Saritha // Golden Research Thoughts;Oct2012, Vol. 2 Issue 4, p1 

    Fungal infections are common in human beings and animals. The recent development of novel antifungal agents as significantly contributed to the successful treatment of fungal dieases. Most of these agents are fungistatic and do not kill the fungal cell. Thus facilitating the emergency of...

  • flucytosine.  // Royal Society of Medicine: Medicines;2002, p250 

    The article provides information on flucytosine, a synthetic antifungal drug which can be used to treat especially serious systemic infections by yeasts and fungi, such as systemic candidiasis. Administration is either oral or by intravenous infusion. It should be administered with caution to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics